Redx Pharma Gestione
Gestione criteri di controllo 3/4
Redx Pharma's CEO is Lisa Mary Anson, appointed in Jun 2018, has a tenure of 5.92 years. total yearly compensation is £608.13K, comprised of 94.9% salary and 5.1% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth £112.75K. The average tenure of the management team and the board of directors is 3 years and 3 years respectively.
Informazioni chiave
Lisa Mary Anson
Amministratore delegato
UK£608.1k
Compenso totale
Percentuale dello stipendio del CEO | 94.9% |
Mandato del CEO | 5.9yrs |
Proprietà del CEO | 0.2% |
Durata media del management | 3yrs |
Durata media del Consiglio di amministrazione | 3yrs |
Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Sep 30 2023 | UK£608k | UK£577k | -UK£33m |
Jun 30 2023 | n/a | n/a | -UK£31m |
Mar 31 2023 | n/a | n/a | -UK£29m |
Dec 31 2022 | n/a | n/a | -UK£24m |
Sep 30 2022 | UK£637k | UK£606k | -UK£18m |
Jun 30 2022 | n/a | n/a | -UK£18m |
Mar 31 2022 | n/a | n/a | -UK£19m |
Dec 31 2021 | n/a | n/a | -UK£20m |
Sep 30 2021 | UK£2m | UK£615k | -UK£22m |
Jun 30 2021 | n/a | n/a | -UK£20m |
Mar 31 2021 | n/a | n/a | -UK£18m |
Dec 31 2020 | n/a | n/a | -UK£14m |
Sep 30 2020 | UK£619k | UK£481k | -UK£9m |
Jun 30 2020 | n/a | n/a | -UK£8m |
Mar 31 2020 | n/a | n/a | -UK£6m |
Dec 31 2019 | n/a | n/a | -UK£5m |
Sep 30 2019 | UK£439k | UK£390k | -UK£4m |
Jun 30 2019 | n/a | n/a | -UK£5m |
Mar 31 2019 | n/a | n/a | -UK£7m |
Dec 31 2018 | n/a | n/a | -UK£8m |
Sep 30 2018 | UK£372k | UK£100k | -UK£9m |
Compensazione vs Mercato: Lisa Mary's total compensation ($USD759.28K) is above average for companies of similar size in the UK market ($USD344.28K).
Compensazione vs guadagni: Lisa Mary's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Lisa Mary Anson (55 yo)
5.9yrs
Mandato
UK£608,127
Compensazione
Mrs. Lisa Mary Whewell Anson serves as the Chief Executive Officer and Executive Director at Redx Pharma PLC since June 1, 2018. She has been President of AstraZeneca UK since 2012 and brings significant l...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO & Executive Director | 5.9yrs | UK£608.13k | 0.19% £ 112.8k | |
Chief Financial Officer | 3yrs | Nessun dato | Nessun dato | |
Chief Operating Officer | 3yrs | UK£210.91k | Nessun dato | |
Chief Scientific Officer | 10.3yrs | Nessun dato | Nessun dato | |
Head of Investor Relations | no data | Nessun dato | Nessun dato | |
General Counsel & Company Secretary | 2.3yrs | Nessun dato | Nessun dato | |
Head of Communications | 2.1yrs | Nessun dato | Nessun dato | |
Senior Vice President of Chemistry | 8.3yrs | Nessun dato | Nessun dato | |
Senior Vice President of Biology | no data | Nessun dato | Nessun dato | |
Head of Development Operations | no data | Nessun dato | Nessun dato | |
Head of Nonclinical Development | 3.3yrs | Nessun dato | Nessun dato | |
Interim Chief Medical Officer | less than a year | Nessun dato | Nessun dato |
3.0yrs
Durata media
55yo
Età media
Gestione esperta: REDX's management team is considered experienced (3 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
CEO & Executive Director | 5.9yrs | UK£608.13k | 0.19% £ 112.8k | |
Independent Non-Executive Director | 6.5yrs | UK£48.75k | 0.038% £ 21.9k | |
Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
Independent Non-Executive Director | 8.3yrs | UK£49.00k | Nessun dato | |
Independent Non-Executive Chair | 2.4yrs | UK£85.00k | 0.022% £ 12.7k | |
Independent Non-Executive Director | 2.3yrs | UK£41.50k | Nessun dato | |
Shareholder Representative Non-Executive Director | 3yrs | Nessun dato | Nessun dato |
3.0yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: REDX's board of directors are considered experienced (3 years average tenure).